Travere Therapeutics Inc Cash Flow-to-Debt Ratio
Travere Therapeutics Inc cash flow-to-debt ratio. Travere Therapeutics Inc (TVTX) has a Cash Flow-to-Debt Ratio of 0.07x as of June 2026, meaning its operating cash flow of $58.07 Million could theoretically repay 0% of its total liabilities ($774.84 Million) in one year. Check cash flow quality index of Travere Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Travere Therapeutics Inc (2010–2025)
Cash flow-to-debt ratio of Travere Therapeutics Inc from 2010 to 2025. Historical debt coverage capacity for Travere Therapeutics Inc across 16 annual periods. Check how aggressively does Travere Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Travere Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2010–2025)
Travere Therapeutics Inc cash flow-to-debt ratio by year from 2010 to 2025. Year-by-year debt coverage analysis for Travere Therapeutics Inc. For the full cash flow conversion analysis, see Travere Therapeutics Inc (TVTX) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | $37.78 Million | $490.36 Million | ▲ +117.4% |
| 2024 | -0.44x | $-237.47 Million | $535.05 Million | ▲ +6.8% |
| 2023 | -0.48x | $-280.02 Million | $588.10 Million | ▼ -61.0% |
| 2022 | -0.30x | $-186.29 Million | $629.73 Million | ▼ -849.0% |
| 2021 | -0.03x | $-14.79 Million | $474.52 Million | ▲ +71.1% |
| 2020 | -0.11x | $-42.74 Million | $396.23 Million | ▲ +28.9% |
| 2019 | -0.15x | $-58.21 Million | $383.60 Million | ▼ -137.7% |
| 2018 | -0.06x | $-24.96 Million | $390.91 Million | ▼ -296.0% |
| 2017 | 0.03x | $7.40 Million | $227.21 Million | ▲ +544.1% |
| 2016 | -0.01x | $-1.60 Million | $217.51 Million | ▼ -181.4% |
| 2015 | 0.00x | $-554.00K | $212.43 Million | ▲ +99.0% |
| 2014 | -0.27x | $-45.85 Million | $172.72 Million | ▲ +41.4% |
| 2013 | -0.45x | $-17.59 Million | $38.81 Million | ▲ +4.0% |
| 2012 | -0.47x | $-2.74 Million | $5.80 Million | ▼ -64418.1% |
| 2011 | 0.00x | $-49.00 | $66.99K | ▲ +93.2% |
| 2010 | -0.01x | $-689.00 | $64.21K | — |